Table 2.
HIV and HTN Cohort (n=115) | HIV and CKD Cohort (n=37) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Scale | HIV M (IQR) |
HTN M (IQR) |
Correlation Coefficient |
p- value |
Z score |
p- value |
HIV M (IQR) |
CKD M (IQR) |
Correlation Coefficient |
p- value |
Z score |
p- value |
Treatment Control |
3.8 (0.5) |
4.0 (0.5) |
0.26 | 0.01 | −2.6 | 0.10 | 3.5 (0.8) |
3.5 (0.8) |
0.21 | 0.21 | −0.63 | 0.53 |
Personal Control | 4.0 (0.7) |
4.0 (1.0) |
0.53 | 0.000 | −0.06 | 0.94 | 4.0 (0.7) |
3.8 (0.7) |
0.26 | 0.12 | −1.90 | 0.057 |
Timeline – Chronic |
3.3 (1.3) |
2.7 (1.3) |
0.36 | 0.000 | −4.7 | <0.01 | 3.2 (1.3) |
2.7 (1.3) |
0.40 | 0.015 | −0.44 | 0.66 |
Timeline – Cyclical |
3.0 (1.5) |
3.5 (1.5) |
0.35 | 0.000 | −3.6 | <0.01 | 3.0 (1.4) |
3.0 (1.4) |
0.41 | 0.013 | −0.08 | 0.94 |
Consequences | 3.3 (1.0) |
2.8 (0.8) |
0.31 | 0.001 | −6.3 | <0.01 | 3.3 (0.9) |
3.0 (0.9) |
0.39 | 0.019 | −1.62 | 0.11 |
Illness Identity | 2.0 (6.0) |
0.0 (2.0) |
0.50 | 0.000 | −5.2 | <0.01 | 0.5 (3.0) |
0.5 (3.0) |
0.59 | 0.000 | −1.10 | 0.27 |
Medication Identity |
1.0 (4.0) |
0.0 (0.0) |
0.42 | 0.000 | −5.7 | <0.01 | 1.0 (3.8) |
0.0 (0.0) |
0.63 | 0.000 | −3.00 | <0.01 |
Emotional Representations |
2.8 (1.4) |
2.0 (0.8) |
0.37 | 0.000 | −5.1 | <0.01 | 2.4 (1.6) |
2.5 (1.0) |
0.44 | 0.008 | −1.03 | 0.30 |
Illness Coherence | 4.0 (0.5) |
4.0 (1.0) |
0.47 | 0.000 | −4.1 | <0.01 | 4.0 (1.3) |
3.8 (1.5) |
0.19 | 0.27 | −1.63 | 0.10 |
Medication Necessity |
4.0 (0.8) |
3.6 (0.9) |
0.46 | 0.000 | −7.2 | <0.01 | 4.0 (0.8) |
3.9 (0.6) |
0.30 | 0.07 | −2.62 | <0.01 |
Medication Concerns |
2.4 (0.7) |
2.2 (0.5) |
0.63 | 0.000 | −4.1 | <0.01 | 2.6 (0.7) |
2.4 (0.6) |
0.23 | 0.17 | −1.82 | 0.069 |
Necessity- Concerns Differential |
1.7 (1.0) |
1.3 (1.0) |
0.57 | 0.000 | −4.5 | <0.01 | 1.4 (1.1) |
1.3 (0.7) |
0.35 | 0.038 | −0.66 | 0.51 |
IQR = Interquartile Range; HTN = hypertension; CKD = chronic kidney disease